KN-93 Phosphate is used as an inhibitor of calcium/calmodulin-dependent protein kinase II (CaMKII), blocking calmodulin binding to the kinase with a Ki of 370 nM; it induces reversible G1 cell cycle arrest; inhibits cell proliferation stimulated by basic fibroblast growth factor (bFGF), platelet-derived growth factor-BB (PDGF-BB), and epidermal growth factor (EGF) in NIH 3T3 fibroblasts; suppresses H+,K+-ATPase activity and dissipates the proton gradient in gastric membrane vesicles; prevents increased left ventricular (LV) developed pressure and early afterdepolarizations during action potential prolongation; and inhibits Ca2+-independent CaM kinase activity associated with early afterdepolarizations.